Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Lung Cancer Res
Main Authors: Ricciuti, Biagio, Lamberti, Giuseppe, Roila, Fausto, Metro, Giulio
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Editorial Commentary
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6987338/
https://ncbi.nlm.nih.gov/pubmed/32038919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.04.15
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki